Position in IONS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$52,702,794
+$5,238,405 QoQ
Shares Held
664,684
+5.2% QoQ
Ownership
0.400%
of shares outstanding
% of Portfolio
2.87%
of 13F equity value
Holder Rank
#43
of 510 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. IONS ranks #5 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
913,880 | $121,783,648 | |
| 2 | VERA |
Vera Therapeutics, Inc.
|
2,212,770 | $94,949,960 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
1,785,941 | $66,454,864 | |
| 4 | SNDX |
Syndax Pharmaceuticals Inc
|
2,798,210 | $61,168,870 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
This page
|
664,684 | $52,702,794 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
798,973 | $45,389,656 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
629,952 | $36,619,109 | |
| 8 | GERN |
Geron Corp
|
18,717,422 | $23,958,300 |
All Filings in IONS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,702,794 | 664,684 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $47,464,389 | 632,100 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $42,578,425 | 538,218 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $35,239,202 | 538,661 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $23,267,439 | 588,900 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,598,523 | 517,021 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,514,721 | 214,952 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,882,481 | 471,355 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,774,948 | 456,881 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $16,318,587 | 376,438 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $16,424,245 | 324,654 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,450,950 | 252,446 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,911,699 | 241,572 | Shares | Sole | 2023-11-08 | |
| 2023-03-31 | $10,842,408 | 303,369 | Shares | Sole | 2023-11-08 | |
| 2022-12-31 | $9,101,625 | 240,975 | Shares | Sole | 2023-11-08 | |
| 2022-09-30 | $8,927,073 | 201,833 | Shares | Sole | 2023-11-08 | |
| 2022-06-30 | $3,195,233 | 86,311 | Shares | Sole | 2023-11-08 | |
| 2022-03-31 | $5,882,174 | 158,806 | Shares | Sole | 2023-11-08 | |
| 2021-12-31 | $11,709,129 | 384,789 | Shares | Sole | 2023-11-08 | |
| 2021-09-30 | $15,109,803 | 450,501 | Shares | Sole | 2023-11-08 | |
| 2021-06-30 | $17,631,380 | 442,000 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||